Introduction
Methods
Animals
Treatments
-
✔ first group of n = 6-10 mice was fed a normal nonpurified diet (N), composed of normal mice pellet (Speciality Feeds, Glen Forrest, Western Australia), containing 4.6% total fat, 4.8% crude fiber and 19% protein (see Diets);
-
✔ second group of n = 6-10 mice was fed a HF diet, containing 21 wt% butterfat and 0.15 wt% cholesterol (SF00-219, Speciality Feeds, WA) (see Diets);
-
✔ third, fourth and fifth groups of n = 6-10 mice, respectively, were fed a high-fat diet with increasing doses of KO (HFKO 1.25, 2.5 and 5), receiving 1.25, 2.5 or 5% wt of KO, respectively. KO (Superba krill oil) was prepared and analyzed by Nutrizeal (Nelson, New Zealand) and supplied by Aker Biomarine (Oslo, Norway) (see Diets).
Diets
control diet | HFD | HFD+1.25 KO | HFD+2.5 KO | HFD+5 KO | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
macro/100g
|
en/100g
|
en%
|
macro/100g
|
en/100g
|
en%
|
macro/100g
|
en/100g
|
en%
|
macro/100g
|
en/100g
|
en%
|
macro/100g
|
en/100g
|
en%
| |
Protein | 20.0 | 80.0 | 22.2 | 19.0 | 76.0 | 16.4 | 19.0 | 76.0 | 16.0 | 19.0 | 76.0 | 15.6 | 19.0 | 76.0 | 14.9 |
Fat | 4.8 | 43.2 | 12.0 | 21.0 | 189.0 | 40.8 | 22.3 | 200.3 | 42.2 | 23.5 | 211.5 | 43.5 | 26.0 | 234.0 | 46.0 |
Carbohydrate | 59.4 | 237.6 | 65.9 | 49.6 | 198.4 | 42.8 | 49.6 | 198.4 | 41.8 | 49.6 | 198.4 | 40.8 | 49.6 | 198.4 | 39.0 |
total | 84.2 | 360.8 | 100.0 | 89.6 | 463.4 | 100.0 | 100.3 | 474.7 | 100.0 | 101.5 | 485.9 | 100.0 | 104.0 | 508.4 | 100.0 |
Composition | control diet | HFD | HFD+1.25 KO | HFD+2.5 KO | HFD+5 KO |
---|---|---|---|---|---|
Fatty Acid | g/100g diet | g/100g diet | g/100g diet | g/100g diet | g/100g diet |
12:0 | 1.80 | 1.80 | 1.81 | 1.82 | |
14:0 | 0.03 | 2.60 | 2.67 | 2.74 | 2.87 |
16:0 | 0.50 | 7.00 | 7.19 | 7.39 | 7.78 |
18:0 | 0.14 | 2.40 | 2.43 | 2.47 | 2.54 |
20:0 | 0.00 | 0.00 | 2.41 | 2.41 | 2.42 |
16:1 | 0.01 | 0.40 | |||
18:1 | 1.90 | 5.50 | 5.90 | 6.31 | 7.11 |
20:1 | 0.03 | 0.00 | |||
18:2n6 | 1.30 | 0.40 | 0.80 | 1.19 | 1.99 |
18:3n3 | 0.30 | 0.20 | 0.25 | 0.30 | 0.41 |
18:4n3 | 0.00 | 0.00 | 0.01 | 0.03 | 0.06 |
20:4n6 | 0.01 | 0.09 | 0.09 | 0.09 | 0.09 |
20:5n3 | 0.02 | 0.05 | 0.10 | 0.16 | 0.26 |
22:6n3 | 0.05 | 0.03 | 0.05 | 0.08 | 0.13 |
Cholesterol | 0.00 | 0.15 | 0.15 | 0.15 | 0.15 |
grams | 4.29 | 20.45 | 23.55 | 24.80 | 27.30 |
tot sat | 0.67 | 13.80 | 16.51 | 16.81 | 17.42 |
tot MUFA | 1.94 | 5.90 | 5.90 | 6.31 | 7.11 |
tot PUFA | 1.68 | 0.60 | 1.13 | 1.66 | 2.71 |
n-6 | 1.31 | 0.40 | 0.80 | 1.20 | 1.99 |
n-3 | 0.37 | 0.20 | 0.33 | 0.46 | 0.72 |
ratio LA/ALA | 4.30 | 2.00 | 3.20 | 3.90 | 4.90 |
Ratio ARA/EPA+DHA | 0.10 | 1.10 | 0.60 | 0.40 | 0.20 |
Synthesis of 1-palmitoyl-2-oleoyl-N-heptadecanoyl phosphatidylethanolamine
Extraction and pre-purification procedures and measurement of AEA, 2-AG, OEA and PEA levels
Enzymatic digestion of 50/50 fractions
LC-MS-IT-TOF analysis
HPLC parameters
Mass parameters
Statistical analysis
Results
Effect of high fat (HF) diet on metabolic parameters and effect of krill oil (KO) on HF-induced alterations
N | HF | HFKO1.25 | HFKO2.5 | HFKO5 | |
---|---|---|---|---|---|
Initial weight (g) | 18.1 ± 0.3 | 18.5 ± 0.8 | 18.0 ± 0.3 | 18.2 ± 0.6 | 18.3 ± 0.8 |
Final weight (g) | 24.6 ± 0.3 | 31.7 ± 0.9### | 31.0 ± 0.9 | 31.8 ± 0.7 | 32.4 ± 1.0 |
Weight gain | 6.5 ± 0.4 | 13.3 ± 1.1### | 13.0 ± 0.9 | 13.6 ± 0.7 | 14.1 ± 0.6 |
TG (mmol/L) | 0.4 ± 0.03 | 0.6 ± 0.06## | 0.8 ± 0.08 | 0.8 ± 0.09 | 0.8 ± 0.06 |
Cholesterol (mmol/L) | 2.6 ± 0.1 | 4.3 ± 0.3### | 3.4 ± 0.1a | 3.0 ± 0.1b | 3.0 ± 0.2b |
PL (mmol/L) | 1.3 ± 0.1 | 1.7 ± 0.1### | 1.5 ± 0.1a | 1.3 ± 0.1c | 1.3 ± 0.1c |
Glucose (mmol/L) | 11.5 ± 0.6 | 13.1 ± 1.6 | 8.3 ± 0.6b | 8.7 ± 0.8a | 7.5 ± 0.8b |
Insulin (mmol/L) | 1.1 ± 0.3 | 0.7 ± 0.1 | 0.6 ± 0.1 | 0.8 ± 0.1 | 0.7 ± 0.1 |
Adiponectin (μg/ml) | 4.7 ± 0.2 | 5.0 ± 0.1 | 6.5 ± 0.3 | 6.5 ± 0.4 | 7.5 ± 0.6a |
Fatty acid synthase
|
109 ± 15
|
44 ± 9
##
|
27 ± 4
|
13 ± 1
c
|
17 ± 2
c
|
Acetyl-CoA carboxylase
|
104 ± 10
|
67 ± 10
##
|
50 ± 5
|
28 ± 3
c
|
32 ± 4
b
|
Stearoyl-CoA desaturase
|
106 ± 11
|
232 ± 43
##
|
154 ± 18
|
55 ± 8
c
|
78 ± 16
c
|
CD36
|
101 ± 5
|
232 ± 28
###
|
256 ± 11
|
131 ± 13
|
219 ± 38
|
Monoacylglycerol lipase
|
102 ± 7
|
146 ± 17
#
|
114 ± 9
|
50 ± 4
c
|
68 ± 7
b
|
Effect of HF and KO on hepatic levels of AEA, 2-AG, OEA and PEA and biosynthetic precursors
Tissue and DAGs | N (pmol/mg) | HF (pmol/mg) | HFKO1.25 (pmol/mg) | HFKO2.5 (pmol/mg) | HFKO5 (pmol/mg) |
---|---|---|---|---|---|
Liver | |||||
18:1-20:4 | 10.8 ± 2.3 | 12.1 ± 2.8 | 7.7 ± 0.5 | 7.1 ± 1.9 | 7.3 ± 1.2 |
16:0-20:4 | 8.9 ± 2.4 | 8.1 ± 1.0 | 4.3 ± 1.0 | 4.2 ± 1.2 | 5.9 ± 1.7 |
18:0-20:4 | 7.6 ± 1.7 | 7.7 ± 1.3 | 11.2 ± 2.3 | 10.5 ± 2.4 | 17.4 ± 0.9* |
Gastrocnemius | |||||
18:1-20:4 | 25.0 ± 3.8 | 17.1 ± 3.3 | 11.5 ± 2.5 | 12.1 ± 3.3 | 17.7 ± 1.8 |
16:0-20:4 | 4.9 ± 1.1 | 8.7 ± 2.3
#
| 3.4 ± 0.7* | 4.2 ± 0.5* | 3.7 ± 0.5* |
18:0-20:4 | 43.6 ± 3.8 | 40.0 ± 7.0 | 27.1 ± 6.0 | 24.9 ± 2.1 | 20.4 ± 1.3* |
Heart | |||||
18:1-20:4 | 3.0 ± 0.2 | 7.2 ± 2.1 | 7.1 ± 0.7 | 5.1 ± 0.4 | 7.1 ± 1.5 |
16:0-20:4 | 0.4 ± 0.1 | 1.2 ± 0.4 | 0.5 ± 0.2 | 0.7 ± 0.2 | 0.4 ± 0.1 |
18:0-20:4 | 11.3 ± 0.6 | 21.1 ± 4.2
#
| 11.8 ± 1.6
*
| 13.2 ± 1.9
*
| 10.1 ± 2.5
*
|
Epididymal adipose tissue | |||||
18:1-20:4 | 12.3 ± 1.9 | 37.0 ± 2.2
###
| 4.3 ± 0.4*** | 4.7 ± 0.7*** | 2.9 ± 1.1*** |
18:0-20:4 | 13.9 ± 4.4 | 16.9 ± 2.2 | 37 ± 0.5*** | 6.8 ± 2.7* | 3.0 ± 1.5** |
Inguinal adipose tissue | |||||
18:1-20:4 | 23.3 ± 3.26 | 16.3 ± 1.2
#
| 9.7 ± 2.9 | 7.5 ± 1.4* | 5.9 ± 0.5** |
16:0-20:4 | - | 6.8 ± 0.8
###
| 2.4 ± 0.4*** | 2.4 ± 0.4*** | 3.2 ± 0.2*** |
18:0-20:4 | 49.8 ± 12.6 | 31.3 ± 6.6 | 20.6 ± 2.2 | 12.5 ± 2.5 | 12.4 ± 1.6 |
Kidney | |||||
18:1-20:4 | 2.0 ± 0.4 | 6.6 ± 1.4
##
| 7.0 ± 0.7 | 3.2 ± 0.5* | 5.1 ± 0.7 |
16:0-20:4 | 1.9 ± 0.1 | 1.3 ± 0.2 | 0.8 ± 0.2 | 1.1 ± 0.2 | 1.3 ± 0.2 |
18:0-20:4 | 10.4 ± 1.5 | 23.8 ± 5.3
#
| 24.1 ± 1.4 | 21.3 ± 5.1 | 24.5 ± 1.3 |
Tissue and NAPEs | N (pmol/mg) | HF (pmol/mg) | HFKO1.25 (pmol/mg) | HFKO2.5 (pmol/mg) | HFKO5 (pmol/mg) |
---|---|---|---|---|---|
Liver | |||||
NPPE | 1.2 ± 0.1 | 1.2 ± 0.1 | 1.7 ± 0.2 | 1.3 ± 0.1 | 2.0 ± 0.08** |
NOPE | 0.3 ± 0.02 | 0.4 ± 0.06 | 0.5 ± 0.06 | 0.3 ± 0.02 | 0.5 ± 0.04* |
NArPE | 0.2 ± 0.02 | 0.2 ± 0.06 | 0.2 ± 0.02 | 0.2 ± 0.03 | 0.2 ± 0.03 |
Gastrocnemius | |||||
NPPE | 1.1 ± 0.2 | 1.1 ± 0.08 | 0.9 ± 0.05 | 0.9 ± 0.09 | 0.7 ± 0.2 |
NOPE | 0.8 ± 0.1 | 0.6 ± 0.04 | 0.5 ± 0.06 | 05 ± 0.06 | 0.4 ± 0.07 |
NArPE | 0.3 ± 0.06 | 0.3 ± 0.05 | 0.1 ± 0.02* | 0.06 ± 0.02** | 0.04 ± 0.01** |
Heart | |||||
NPPE | 1.7 ± 0.05 | 1.7 ± 0.2 | 1.8 ± 0.2 | 1.6 ± 0.1 | 1.5 ± 0.1 |
NOPE | 0.2 ± 0.02 | 0.3 ± 0.01 | 0.3 ± 0.04 | 0.3 ± 0.03 | 0.2 ± 0.03 |
NArPE | 0.2 ± 0.03 | 0.3 ± 0.05 | 0.2 ± 0.01 | 0.2 ± 0.03 | 0.1 ± 0.02** |
Epididymal adipose tissue | |||||
NPPE | 3.6 ± 0.5 | 3.7 ± 1.2 | 1.6 ± 0.2 | 2.5 ± 0.4 | 1.9 ± 0.5 |
NOPE | 2.9 ± 0.3 | 1.2 ± 0.1
###
| 0.9 ± 0.2 | 1.1 ± 0.2 | 1.1 ± 0.3 |
NArPE | 0.1 ± 0.02 | 0.3 ± 0.09
#
| 0.07 ± 0.01* | 0.1 ± 0.07* | 0.04 ± 0.01* |
Inguinal adipose tissue | |||||
NPPE | 2.8 ± 0.5 | 3.3 ± 0.8 | 2.1 ± 0.6 | 2.0 ± 0.4 | 1.5 ± 0.6 |
NOPE | 3.1 ± 0.6 | 4.2 ± 1.1 | 2.3 ± 0.7 | 2.3 ± 0.4 | 1.6 ± 0.7 |
NArPE | 0.3 ± 0.09 | 0.6 ± 0.2 | 0.4 ± 0.1 | 0.4 ± 0.03 | 0.3 ± 0.07 |
Kidney | |||||
NPPE | 1.2 ± 0.2 | 1.4 ± 0.2 | 1.4 ± 0.1 | 1.2 ± 0.12 | 1.1 ± 0.1 |
NOPE | 1.1 ± 0.2 | 0.9 ± 0.2 | 0.8 ± 0.06 | 0.6 ± 0.05 | 0.5 ± 0.06 |
NArPE | 1.1 ± 0.2 | 1.7 ± 0.2 | 1.0 ± 0.06 | 0.6 ± 0.7 | 0.5 ± 0.06 |